Graf Akcie CRNX (Crinetics Pharmaceuticals Inc). Diskuze k akciím CRNX. Aktuální informace CRNX.

Základní informace o společnosti Crinetics Pharmaceuticals Inc (Akcie CRNX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	733.45M
Hodnota podniku (EV)	N/A
Tržby	0.00
EBITDA	N/A
Zisk	-88.96
Růst v tržbách Q/Q	N/A %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-0.70
EV/Sales	6,629.82
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	4.34
Účetní hodnota na akcii	4.50
Hotovost na akcii	4.56
FCF vůči ceně	-10.14 %
Počet zaměstnanců	93
Tržba na zaměstnance	0.00
Profit margin	-103,960.56 %
Operating margin	N/A %
Gross margin	100.00 %
EBIT margin	N/A %
EBITDA margin	-13,753.06 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	32.08 %
EPS - Očekávaný růst příští rok	28.57 %
Return on assets	-46.56 %
Return on equity	-50.32 %
ROIC	-47.04 %
ROCE	-43.39 %
Dluhy/Equity	0.09
Čistý dluh/EBITDA	11.26
Current ratio	17.73
Quick Ratio	17.73
Volatilita	4.88
Beta	1.39
RSI	35.37
Cílová cena analytiků	33
Známka akcie (dle analytiků)	1.40
Insider ownership	3.85 %
Institutional ownership	89.11 %
Počet akcií	38.564M
Procento shortovaných akcií	4.27 %
Short ratio	8.06 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	1970
Země	United States

Finanční výsledky akcie CRNX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017
Revenue	$1.193	$2.428	$2.045	$0.589
Cost Of Goods Sold	-	-	-	-
Gross Profit	$1.193	$2.428	$2.045	$0.589
Research And Development Expenses	$41.506	$24.479	$9.233	$5.1
SG&A Expenses	$13.519	$6.659	$1.939	$1.533
Other Operating Income Or Expenses	-	-	-	-
Operating Expenses	$55.025	$31.138	$11.172	$6.633
Operating Income	$-53.832	$-28.71	$-9.127	$-6.044
Total Non-Operating Income/Expense	$3.41	$1.595	$-0.03	$0.025
Pre-Tax Income	$-50.422	$-27.115	$-9.157	$-6.019
Income Taxes	-	-	-	-
Income After Taxes	$-50.422	$-27.115	$-9.157	$-6.019
Other Income	-	-	-	-
Income From Continuous Operations	$-50.422	$-27.115	$-9.157	$-6.019
Income From Discontinued Operations	-	-	-	-
Net Income	$-50.422	$-27.115	$-9.157	$-6.019
EBITDA	$-54.174	$-28.672	$-8.999	$-5.952
EBIT	$-53.832	$-28.71	$-9.127	$-6.044
Basic Shares Outstanding	24	12	1	1
Shares Outstanding	24	12	1	1
Basic EPS	$-2.09	$-2.23	$-6.68	$-5.96
EPS - Earnings Per Share	$-2.09	$-2.23	$-6.68	$-5.96

#	2020	2019	2018	2017
Cash On Hand	$118.392	$163.875	$14.192	$12.152
Receivables	-	-	-	-
Inventory	-	-	-	-
Pre-Paid Expenses	$4.947	$2.808	$0.973	$0.213
Other Current Assets	-	-	-	-
Total Current Assets	$123.339	$166.683	$15.165	$12.365
Property, Plant, And Equipment	$3.946	$4.232	$0.4	$0.224
Long-Term Investments	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-
Other Long-Term Assets	$0.582	$0.5	$0.033	$0.01
Total Long-Term Assets	$7.038	$4.732	$0.433	$0.234
Total Assets	$130.377	$171.415	$15.598	$12.599
Total Current Liabilities	$8.34	$7.925	$0.897	$0.89
Long Term Debt	-	-	-	$0.163
Other Non-Current Liabilities	-	-	-	-
Total Long Term Liabilities	$4.898	$3.265	$0.023	$0.173
Total Liabilities	$13.238	$11.19	$0.92	$1.063
Common Stock Net	$210.793	$203.544	$0.001	$0.001
Retained Earnings (Accumulated Deficit)	$-93.802	$-43.38	$-16.265	$-7.108
Comprehensive Income	$0.148	$0.061	-	-
Other Share Holders Equity	-	-	-	-
Share Holder Equity	$117.139	$160.225	$14.678	$11.536
Total Liabilities And Share Holders Equity	$130.377	$171.415	$15.598	$12.599

#	2020	2019	2018	2017
Net Income/Loss	$-50.422	$-27.115	$-9.157	$-6.019
Total Depreciation And Amortization - Cash Flow	$-0.342	$0.038	$0.128	$0.092
Other Non-Cash Items	$6.516	$2.32	$0.271	$0.27
Total Non-Cash Items	$6.174	$2.358	$0.399	$0.362
Change In Accounts Receivable	-	-	-	-
Change In Inventories	-	-	-	-
Change In Accounts Payable	-	-	-	-
Change In Assets/Liabilities	$-2.829	$-2.063	$-0.768	$-0.111
Total Change In Assets/Liabilities	$-2.133	$5.298	$-0.721	$0.189
Cash Flow From Operating Activities	$-46.381	$-19.459	$-9.479	$-5.468
Net Change In Property, Plant, And Equipment	$-0.492	$-1.059	$-0.304	$-0.19
Net Change In Intangible Assets	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-
Net Change In Short-term Investments	$42.159	$-118.399	-	-
Net Change In Long-Term Investments	-	-	-	-
Net Change In Investments - Total	$42.159	$-118.399	-	-
Investing Activities - Other	-	-	-	-
Cash Flow From Investing Activities	$41.667	$-119.458	$-0.304	$-0.19
Net Long-Term Debt	-	-	$-0.212	$-0.048
Net Current Debt	-	-	-	-
Debt Issuance/Retirement Net - Total	-	-	$-0.212	$-0.048
Net Common Equity Issued/Repurchased	$0.067	$106.923	$0.066	-
Net Total Equity Issued/Repurchased	$0.067	$170.198	$12.035	$-0.005
Total Common And Preferred Stock Dividends Paid	-	-	-	-
Financial Activities - Other	-	-	-	-
Cash Flow From Financial Activities	$0.067	$170.198	$11.823	$-0.053
Net Cash Flow	$-4.647	$31.281	$2.04	$-5.711
Stock-Based Compensation	$6.294	$2.32	$0.271	$0.27
Common Stock Dividends Paid	-	-	-	-

#	2020	2019	2018	2017
Current Ratio	14.7889	21.0326	16.9064	13.8933
Long-term Debt / Capital	-	-	-	0.0139
Debt/Equity Ratio	-	-	-	0.0184
Gross Margin	100	100	100	100
Operating Margin	-4512.322	-1182.455	-446.308	-1026.146
EBIT Margin	-4512.322	-1182.455	-446.308	-1026.146
EBITDA Margin	-4540.989	-1180.89	-440.0489	-1010.526
Pre-Tax Profit Margin	-4226.488	-1116.763	-447.775	-1021.901
Net Profit Margin	-4226.488	-1116.763	-447.775	-1021.902
Asset Turnover	0.0092	0.0142	0.1311	0.0467
Inventory Turnover Ratio	-	-	-	-
Receiveable Turnover	-	-	-	-
Days Sales In Receivables	-	-	-	-
ROE - Return On Equity	-43.0446	-16.9231	60.9573	97.018
Return On Tangible Equity	-43.0446	-16.9231	-62.3859	-52.1758
ROA - Return On Assets	-38.674	-15.8183	-58.7062	-47.7736
ROI - Return On Investment	-43.0446	-16.9231	-62.3859	-51.4488
Book Value Per Share	4.8279	6.6591	9.4697	9.9021
Operating Cash Flow Per Share	-0.316	5.3113	-1.5054	-5.4085
Free Cash Flow Per Share	-0.2491	5.4459	-1.5393	-5.5964

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/CRNX', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie CRNX (Crinetics Pharmaceuticals Inc). Diskuze k akciím CRNX. Aktuální informace CRNX.

Základní informace o společnosti Crinetics Pharmaceuticals Inc (Akcie CRNX)

Finanční výsledky akcie CRNX